BA
SILK

Bridgewater Associates’s Silk Road Medical, Inc. Common Stock SILK Stock Holding History

Bridgewater Associates’s Portfolio SILK Stock Details SILK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-31,316
Closed -$847K – 955
2024
Q2 		$847K Buy
31,316
+5,172
+20% +$108K ﹤0.01% 692
2024
Q1 		$479K Buy
+26,144
New +$415K ﹤0.01% 627
2023
Q4 		– Sell
-45,227
Closed -$678K – 818
2023
Q3 		$678K Buy
45,227
+3,644
+9% +$75.8K ﹤0.01% 660
2023
Q2 		$1.35M Sell
41,583
-4,040
-9% -$148K 0.01% 532
2023
Q1 		$1.79M Buy
45,623
+1,827
+4% +$89.4K 0.01% 477
2022
Q4 		$2.31M Sell
43,796
-10,575
-19% -$515K 0.01% 507
2022
Q3 		$2.45M Buy
54,371
+421
+0.8% +$18.1K 0.01% 519
2022
Q2 		$1.96M Buy
53,950
+8,332
+18% +$303K 0.01% 687
2022
Q1 		$1.88M Buy
45,618
+10,477
+30% +$369K 0.01% 695
2021
Q4 		$1.5M Buy
35,141
+1,687
+5% +$84.4K 0.01% 505
2021
Q3 		$1.84M Sell
33,454
-2,272
-6% -$119K 0.01% 442
2021
Q2 		$1.71M Buy
+35,726
New +$1.82M 0.01% 517

Other funds holding SILK

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Bridgewater Associates's SILK Position: Q3 2024 in Review

Bridgewater Associates sold out of Silk Road Medical, Inc. Common Stock (SILK) in Q3 2024, closing a stake of 31,316 shares — an estimated $847K sold.

Bridgewater Associates first reported a position in SILK in Q2 2021 and held it in 12 quarters. The position peaked at $2.45M in Q3 2022. 1 fund tracked by Wall St. Rank holds SILK as of Q3 2024.

  • Bridgewater Associates reported no remaining Silk Road Medical, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Bridgewater Associates sold 31,316 Silk Road Medical, Inc. Common Stock shares in Q3 2024, an estimated $847K.
  • Bridgewater Associates first reported a position in Silk Road Medical, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
  • Bridgewater Associates's Silk Road Medical, Inc. Common Stock position peaked at $2.45M in Q3 2022.
  • 1 fund tracked by Wall St. Rank held Silk Road Medical, Inc. Common Stock as of Q3 2024.

Based on Bridgewater Associates's 13F filing for Q3 2024, filed 13 Nov 2024.